Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07821398 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis

Name: Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis — clinical trial record (NCT07821398)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorBastiaan Driehuys

Started2026-11-01

View on ClinicalTrials.gov ↗

Bastiaan Driehuys

11 trials monitored

See all monitored trials

Hypertension

1,786 trials monitored

See 77 trials at risk

Scleroderma

302 trials monitored

See 9 trials at risk

This study aims to evaluate a noninvasive magnetic resonance imaging technique using hyperpolarized xenon gas to measure lung function in adults with interstitial lung disease, pulmonary hypertension, and systemic sclerosis. Researchers will assess whether MRI measurements correlate with clinical measures of lung and vascular function.

Trial Details

NCT Number	NCT07821398
Lead Sponsor	Bastiaan Driehuys Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions	Interstitial Lung Disease, Pulmonary Hypertension, Systemic Sclerosis
Enrollment	51 participants
Start Date	2026-11-01
Primary Completion	2030-04-20 (estimated)
Study Completion	2030-04-20 (estimated)
Updated on ClinicalTrials.gov	2026-09-15